Cargando…

Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D

PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating chronic lung disease with a high symptom burden, which has a substantial impact on health-related quality of life (HRQoL). Our study aimed to assess the suitability of the EuroQol five-dimension (EQ-5D-5L) and the Assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Ingrid A., Campbell, Julie, de Graaff, Barbara, Otahal, Petr, Corte, Tamera J., Moodley, Yuben, Hopkins, Peter, Macansh, Sacha, Walters, E. Haydn, Palmer, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911478/
https://www.ncbi.nlm.nih.gov/pubmed/35927542
http://dx.doi.org/10.1007/s11136-022-03205-z
_version_ 1784884998302597120
author Cox, Ingrid A.
Campbell, Julie
de Graaff, Barbara
Otahal, Petr
Corte, Tamera J.
Moodley, Yuben
Hopkins, Peter
Macansh, Sacha
Walters, E. Haydn
Palmer, Andrew J.
author_facet Cox, Ingrid A.
Campbell, Julie
de Graaff, Barbara
Otahal, Petr
Corte, Tamera J.
Moodley, Yuben
Hopkins, Peter
Macansh, Sacha
Walters, E. Haydn
Palmer, Andrew J.
author_sort Cox, Ingrid A.
collection PubMed
description PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating chronic lung disease with a high symptom burden, which has a substantial impact on health-related quality of life (HRQoL). Our study aimed to assess the suitability of the EuroQol five-dimension (EQ-5D-5L) and the Assessment of Quality of Life- eight-dimension (AQoL-8D) questionnaires in measuring HRQoL as health state utility values (HSUVs) in an Australian IPF cohort. METHODS: Data for estimation of health state utility values (HSUVs) were collected from participants of the Australian IPF Registry (AIPFR) using self-administered surveys which included the EQ-5D-5L and the AQoL-8D. Data on lung function and disease specific HRQoL instruments were collected from the AIPFR. Performance of the two instruments was evaluated based on questionnaire practicality, agreement between the two instruments and test performance (internal and construct validity). RESULTS: Overall completion rates for the EQ-5D-5L and AQoL-8D were 96% and 85%, respectively. Mean (median) HSUVs were 0.65 (0.70) and 0.69 (0.72) for the EQ-5D-5L and AQoL-8D, respectively. There was reasonable agreement between the two instruments based on the Bland–Altman plot mean difference (−0.04) and intraclass correlation coefficient (0.84), however there were some fundamental differences. A larger range of values was observed with the EQ-5D-5L (−0.57–1.00 vs 0.16–1.00). The EQ-5D-5L had a greater divergent sensitivity and efficacy in relation to assessing HSUVs between clinical groupings. The AQoL-8D ,however, had a higher sensitivity to measure psychosocial aspects of HRQoL in IPF. CONCLUSION: The EQ-5D-5L demonstrated superior performance when compared to AQoL-8D in persons with IPF. This may be attributable to the high symptom burden which is physically debilitating to which the EQ-5D-5L may be more sensitive. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-022-03205-z.
format Online
Article
Text
id pubmed-9911478
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99114782023-02-11 Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D Cox, Ingrid A. Campbell, Julie de Graaff, Barbara Otahal, Petr Corte, Tamera J. Moodley, Yuben Hopkins, Peter Macansh, Sacha Walters, E. Haydn Palmer, Andrew J. Qual Life Res Article PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating chronic lung disease with a high symptom burden, which has a substantial impact on health-related quality of life (HRQoL). Our study aimed to assess the suitability of the EuroQol five-dimension (EQ-5D-5L) and the Assessment of Quality of Life- eight-dimension (AQoL-8D) questionnaires in measuring HRQoL as health state utility values (HSUVs) in an Australian IPF cohort. METHODS: Data for estimation of health state utility values (HSUVs) were collected from participants of the Australian IPF Registry (AIPFR) using self-administered surveys which included the EQ-5D-5L and the AQoL-8D. Data on lung function and disease specific HRQoL instruments were collected from the AIPFR. Performance of the two instruments was evaluated based on questionnaire practicality, agreement between the two instruments and test performance (internal and construct validity). RESULTS: Overall completion rates for the EQ-5D-5L and AQoL-8D were 96% and 85%, respectively. Mean (median) HSUVs were 0.65 (0.70) and 0.69 (0.72) for the EQ-5D-5L and AQoL-8D, respectively. There was reasonable agreement between the two instruments based on the Bland–Altman plot mean difference (−0.04) and intraclass correlation coefficient (0.84), however there were some fundamental differences. A larger range of values was observed with the EQ-5D-5L (−0.57–1.00 vs 0.16–1.00). The EQ-5D-5L had a greater divergent sensitivity and efficacy in relation to assessing HSUVs between clinical groupings. The AQoL-8D ,however, had a higher sensitivity to measure psychosocial aspects of HRQoL in IPF. CONCLUSION: The EQ-5D-5L demonstrated superior performance when compared to AQoL-8D in persons with IPF. This may be attributable to the high symptom burden which is physically debilitating to which the EQ-5D-5L may be more sensitive. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-022-03205-z. Springer International Publishing 2022-08-04 2023 /pmc/articles/PMC9911478/ /pubmed/35927542 http://dx.doi.org/10.1007/s11136-022-03205-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Cox, Ingrid A.
Campbell, Julie
de Graaff, Barbara
Otahal, Petr
Corte, Tamera J.
Moodley, Yuben
Hopkins, Peter
Macansh, Sacha
Walters, E. Haydn
Palmer, Andrew J.
Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
title Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
title_full Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
title_fullStr Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
title_full_unstemmed Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
title_short Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
title_sort assessment of health-related quality of life in australian patients with idiopathic pulmonary fibrosis: a comparison of the eq-5d-5l and the aqol-8d
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911478/
https://www.ncbi.nlm.nih.gov/pubmed/35927542
http://dx.doi.org/10.1007/s11136-022-03205-z
work_keys_str_mv AT coxingrida assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT campbelljulie assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT degraaffbarbara assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT otahalpetr assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT cortetameraj assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT moodleyyuben assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT hopkinspeter assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT macanshsacha assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT waltersehaydn assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d
AT palmerandrewj assessmentofhealthrelatedqualityoflifeinaustralianpatientswithidiopathicpulmonaryfibrosisacomparisonoftheeq5d5landtheaqol8d